Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

詳細情報 詳細情報について

• CRID

  1363107368736012160

• DOI

  10.1016/s0140-6736(10)61384-0

• ISSN

  01406736

  http://id.crossref.org/issn/01406736

• Web Site

  https://api.elsevier.com/content/article/PII:S0140673610613840?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0140673610613840?httpAccept=text/plain

• データソース種別

  • Crossref